Bariatric surgery outpaces GLP-1s for diabetes, SDOH: Study
In a review of 258 patients with Type 2 diabetes who underwent metabolic bariatric surgery or medical and lifestyle interventions, including GLP-1 drugs, surgery was superior regardless of social determinants of health. The research, published Jan. 20 in Annals of Internal Medicine, pulls from randomized clinical trials conducted across four U.S. academic medical centers. These […]
Continue Reading